Sensitization to lipopolysaccharide in mice with asymptomatic viral infection: Role of T cell-dependent production of interferon-γ

Journal of Infectious Diseases

Volumn 176, Issue 1, 1997, Pages 151-157

  Nansen, A ^a   Christensen, J Pravsgaard ^a   Marker, O ^a   Thomsen, A Randrup ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOREGULATION; IMMUNOSTIMULATION; INTERFERON PRODUCTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

EID: 0030982262     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514017     Document Type: Article

References (16)

1. Glauser MP, Zanetti G, Baumgartner JD, Cohen J. Septic shock: pathogenesis. Lancet 1991;338:732-9.
2. Heinzel FP. The role of IFN-gamma in the pathology of experimental endotoxemia. J Immunol 1990;145:2920-4.
3. Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J Immunol 1992;149:1666-70.
4. Rothe J, Lessiauer W, Lötscher H, et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993;364:798802.
5. Stout RD. Macrophage activation by T cells: cognate and non-cognate signals. Curr Opin Immunol 1993;5:398-403.
6. Drapier JC, Wietzerbin J, Hibbs JB Jr. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 1988;181:587-92.
7. Liew FY, Li Y, Millott S. Tumor necrosis factor-α synergizes with interferon-γ in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 1990;145:4306-10.
8. Beckermann KP, Rogers HW, Corbett JA, Schreiber RD, McDaniel ML, Unanue ER. Release of nitric oxide during the T cell-independent pathway of macrophage activation. J Immunol 1993;150:888-95.
9. Williams JG, Jurkovidch GJ, Hahnel GB, Maier RV. Macrophage priming by Interferon gamma: a selective process with potential harmful effects. J Leukoc Biol 1992;52:579-84.
10. Kohler J, Heumann D, Garotta G, et al. Interferon-γ involvement in the severity of gram-negative infections in mice. J Immunol 1993;151: 916-2.
11. Ruggiero V, Tavernier J, Fiers W, Baglioni C. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma. J Immunol 1986:136:2445-50.
12. Tsujimoto M, Yip YK, Vilcek J. Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor. J Immunol 1986;136: 2441-4.
13. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
14. Gérard C, Bruyns C, Marchant A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993;177:547-50.
15. Barsig J, Küsters S, Vogt K, Volk H, Tiegs G, Wendel A. Lipopolysaccha-ride-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-α. Eur J Immunol 1995;25:2888-93.
16. van der Poll T, Marchant A, Buurman WA, et al. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 1995; 155:5397-401.